Built for clinical research advertising.
Recruitment advertising for research is not like marketing anything else. It runs inside IRB oversight, strict platform health policies, and real participant-privacy obligations. Working within those rules is not a constraint we tolerate. It is the foundation of how every campaign is built.
Each of these shapes what an ad can say, where it can run, and how participant information is handled. Campaigns are designed around all of them from the start.
Recruitment creative is developed from your IRB-approved study materials and submitted through your institution's review process before anything runs. Nothing goes live without sign-off.
Meta restricts how health conditions can be referenced in ads. Copy is written to speak generally and let people self-identify, rather than implying personal health details, which keeps campaigns within policy.
Ad accounts that run health ads get extra scrutiny. Campaigns are built and paced to keep the account in good standing, and a rejected ad is reviewed and appealed rather than resubmitted blindly.
Interested participants are routed to your approved screener or interest form. Their information goes to your research team, not used for retargeting, list building, or any purpose outside helping direct them to your study.
Every campaign follows the same path, so your team and your reviewers always see the materials before a participant does.
Creative and copy are drafted from your IRB-approved study documents.
You and your reviewers see every ad, headline, and landing destination first.
Materials go through your institution's review process as required before launch.
Approved campaigns go live and are monitored, ready to adjust if a platform flags anything.
Short answers to the rules that come up on nearly every study. Your IRB's own policies always take precedence, and TrialFill builds to them. For the full rules, with what FDA guidance says an ad may and may not include, read the clinical trial advertising guidelines. For what a compliant ad actually looks like, see clinical trial advertising.
Yes. FDA guidance treats recruitment advertising as the start of the informed consent process, so the IRB reviews and approves it before it runs. That includes social media ads, search ads, landing pages, images, video, and the wording of screener questions, not just printed flyers. The IRB checks that the ad is accurate, does not promise benefits or a cure, and does not put undue emphasis on payment. Any change after approval, even a new headline or image, goes back to the IRB before it runs.
Requirements vary by institution, but a compliant ad typically states that it is a research study, names the institution or principal investigator, describes the purpose in plain language, summarizes who may be eligible, and gives a way to contact the study team. Many IRBs also require the study's IRB number on the ad. It must not overstate benefits, promise a cure or improvement, or imply the treatment is known to be safe or effective.
Often yes, if the IRB approves the language. Compensation cannot be emphasized with larger type, bold text, or dollar amounts in headlines, and Meta applies its own limits on how payment is presented. TrialFill writes it as a plain statement of fact, when it is included at all, so the ad clears both reviews.
IRB approval and platform approval are separate. A fully approved study can still have its ad rejected under a health-advertising policy. When that happens, TrialFill adjusts the ad to meet the platform rule without changing anything the IRB approved, resubmits it, and absorbs the cost. Your ad account stays in good standing.
Any change to wording, images, eligibility statements, or the landing destination goes back to the IRB before it runs. Format-only changes a platform requires, such as a cropped image or a shortened headline, are handled with your team and documented so the approved content stays intact.
A study can be fully IRB-approved and still have its ads rejected by Meta, because the platform enforces its own separate health-advertising rules. TrialFill builds for both, so your approved study does not get held up by an avoidable ad rejection.
Talk through your study's requirements